TrialAmerican journal of hematology2022

Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial.

Annelies van Vuren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.